•
Mar 31, 2013

Jazz Pharmaceuticals Q1 2013 Earnings Report

Total Revenue
$196M
Previous year: $103B
-99.8%
EPS
$1.37
Previous year: $0.48
+185.4%
Gross Profit
$169M
Previous year: $97.7M
+73.1%
Cash and Equivalents
$451M
Previous year: $171M
+164.0%
Total Assets
$2.01B
Previous year: $895M
+124.5%

Jazz Pharmaceuticals

Jazz Pharmaceuticals